InSyBio: Funding, Investors & Team (Oct 2026)
InSyBio, a pioneering biotechnology company, specializes in personalized healthcare and nutrition. They focus on developing computational tools and frameworks to analyze complex life-science and biological data. The main goal of their analysis is to discover predictive integrated biosignatures (biomarkers from various categories) and models that have improved prognostic and diagnostic aspects for the healthcare and nutrition industries. Their key products include the InSyBio Suite, a SaaS platform that streamlines the analysis of biomedical multi-omics data, reducing time and resources needed by 80% and increasing the accuracy of predictive models by at least 10%. They also offer the InSyBio Personalization Test, a customized product for nutrition companies that allows for personalized nutrition, nutraceutical, vitamin, and probiotic products. InSyBio has participated in programs such as NBG Business Seeds by the National Bank of Greece since June 2015, and the Loyal VC program since 2021.
InSyBio has raised $100k across 1 funding round on record, the most recent a Series A of $100k announced in Jul 2023.
That round is below the $6.0M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
InSyBio Company Profile and Key Stats
Latest funding round on record: Jul 2023.
InSyBio Funding Rounds
InSyBio Founders and Leadership Team
Contact details for the InSyBio team: 1 of 1 has an email address on file.
Start 14-day free trial →InSyBio Funding Compared to Other Artificial Intelligence Startups
InSyBio's latest round of $100k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like InSyBio in Artificial Intelligence and Narragansett
Companies Similar to InSyBio
Biotia is a health tech company spun out of Cornell Tech leveraging next-generation sequencing and artificial…
The hardest unsolved problem in robotics isn't perception or locomotion, it's dexterity. Tangent Robotics…
Autopoiesis Sciences creates advanced AI models that aim to enable groundbreaking scientific advancements…
The EnCharge AI platform provides a reliable computing solution that enables the utilization of highly…
EliseAI offers AI-powered automation and conversational services tailored for housing and healthcare…
Reco is an innovative security software company that offers a platform to assist organizations in monitoring…
General Intuition is a frontier research lab focused on teaching machines to learn and adapt through play.
Dodge AI is an enterprise automation platform that specializes in ERP maintenance.
ARTDAI is the leader in unbiased, data-driven research and information on fine art transactions worldwide.…
SiMa.ai is a company that specializes in developing machine learning technology for embedded edge systems,…
Modulate’s voice skins will be available through select platforms via Modulate’s real-time software…
Quartermaster AI is a defense technology company that develops real-time distributed marine software via AI…
InSyBio Funding FAQs
What does InSyBio do?
InSyBio, a pioneering biotechnology company, specializes in personalized healthcare and nutrition. They focus on developing computational tools and frameworks to analyze complex life-science and biological data. The main goal of their analysis is to discover predictive integrated biosignatures (biomarkers from various categories) and models that have improved prognostic and diagnostic aspects for the healthcare and nutrition industries. Their key products include the InSyBio Suite, a SaaS platform that streamlines the analysis of biomedical multi-omics data, reducing time and resources needed by 80% and increasing the accuracy of predictive models by at least 10%. They also offer the InSyBio Personalization Test, a customized product for nutrition companies that allows for personalized nutrition, nutraceutical, vitamin, and probiotic products. InSyBio has participated in programs such as NBG Business Seeds by the National Bank of Greece since June 2015, and the Loyal VC program since 2021.
How much funding has InSyBio raised?
InSyBio has raised $100k across 1 round on record. The most recent is a Series A of $100k announced in Jul 2023.
When did InSyBio last raise funding?
InSyBio's most recent funding round on record is a Series A of $100k, announced in Jul 2023.
Who is the CEO of InSyBio?
Labros Digonis is listed as CEO at InSyBio.
Where is InSyBio headquartered?
InSyBio is based in Narragansett, Rhode Island, United States.
How many employees does InSyBio have?
InSyBio is in the 1-10 employee band.
How does InSyBio's funding compare to other Artificial Intelligence startups?
InSyBio's latest round of $100k is below the $6.0M median round size for Artificial Intelligence companies on FundedIQ across 7,239 tracked companies over the last two years.
About FundedIQ's InSyBio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for InSyBio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.